Sofia Michael J. 4
4 · Arbutus Biopharma Corp · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Sofia Michael J.
Chief Scientific Officer
Transactions
- Award
Stock Options
2021-02-13+290,000→ 290,000 totalExercise: $4.33Exp: 2031-02-13→ Common Stock (290,000 underlying)
Footnotes (1)
- [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.